NEW YORK (GenomeWeb News) – German firm Miltenyi Biotec today announced it has completed its acquisition of microchip cell sorting company Owl Biomedical for an undisclosed amount.
Based in Santa Barbara, Calif., Owl was founded in 2011. Its first product, called the Nanosorter, uses a closed fluid path cartridge for "plug and play" cell sorting. The technology can process samples efficiently in a clean environment isolated from the laboratory setting, Miltenyi said.
"This acquisition combines Owl's innovative microchip-based, high speed cell sorting technology and intellectual property with Miltenyi Biotec's strength in commercial design, manufacturing and marketing," John Foster, president of Owl, said in a statement. "This combination provides assurance that our technology will get to market in a timely manner with the highest quality engineering."
Based in Bergisch Gladbach, Germany, Miltenyi provides products and services for biomedical research.